Venture capital · Early stage
EPIDAREX CAPITAL MANAGEMENT LLC
Epidarex is a venture capital firm that provides equity capital to early-stage life science and health technology companies, including university spin-outs, in under-ventured research hubs in the UK and US.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is EPIDAREX CAPITAL MANAGEMENT LLC right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds EPIDAREX CAPITAL MANAGEMENT LLC joined, from press and the firm’s own posts.
Every round EPIDAREX CAPITAL MANAGEMENT LLC joined
Round sizes, EPIDAREX CAPITAL MANAGEMENT LLC’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet EPIDAREX CAPITAL MANAGEMENT LLC
Events where EPIDAREX CAPITAL MANAGEMENT LLC’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
EPIDAREX CAPITAL MANAGEMENT LLC is based in Bethesda, United States. It also has an office in Edinburgh.
3 fund vehicles are on public registers (SEC adviser filings), including EPIDAREX CAPITAL III US, LP, EPIDAREX II SPV, LP and EPIDAREX CAPITAL IV, LP.
Stages: Early stage. Sectors: Life sciences, Health tech. From the firm’s own website.
Epidarex uses its scientific and industry network to find transformative life science opportunities in regions with little venture funding. It builds companies from scratch, working closely with founders and management to turn research into successful businesses. From the firm’s own website.
Know before EPIDAREX CAPITAL MANAGEMENT LLC’s next round is announced.
PRO tracks EPIDAREX CAPITAL MANAGEMENT LLC’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.